DLH Q3 revenue $66.4M (+8% YoY), EPS $0.34, operating margin 10.7%

DLH Holdings Corp.

2022-Q3 EPS reported $1.40 revenue$327,940,000

Revenue $66.4M, up 8% YoY; net income $4.9M vs $2.9M; diluted EPS $0.34 vs $0.21.
Operating margin improved to 10.7% from 8.0% on higher revenue, better mix, and lower fringe costs.
Debt reduced to $28.5M from $37.5M at March 31, 2022; total backlog $509.7M.
Won DoD health R&D IDIQ and NIH National Cancer Institute clinical research contract.
EBITDA $9.0M (13.5% of revenue) vs $7.0M (11.3%) in prior year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.